Pentose phosphate pathway & GAGs Flashcards

1
Q

The pentose phosphate pathway involves the oxidation of Glucose-6-phosphate to this

A

Pentose-5-phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The pentose phosphate pathway involves the oxidation of this to pentose-5-phosphate

A

Glucose-6-phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Used in RBCs to determine thiamine status/deficiency

A

Transketolase assay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Transketolase assay is used in RBCs to determine the status of this

A

Thiamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Is the NADPH:NADP+ ratio high or low in the cytoplasm?

A

High, favors reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Is the NADH:NAD+ ratio high or low in the cytoplasm?

A

Low, favors oxidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

3 main functions of the pentose phosphate pathway

A

Reduction of NADP+ to NADPH
Reduction of glutathione (for destruction of ROS)
Synthesis of ribose-5-phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Enzyme that provides protection against ROS

A

Glucose-6-phosphate dehydrogenase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Oxidation product derived from unsaturated fatty acids used to test for ROS

A

Malondialdehyde

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Main cellular source of ROS in normoxia, hypoxia, and especially after oxygen reperfusion after a period of hypoxia

A

Mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ROS formed by the mitochondria when ATP is high or low?

A

High ATP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ROS formed by the mitochondria when membrane potential is high or low?

A

High membrane potential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ROS formed by the mitochondria when electron transport is slow or fast?

A

Slow rate of electron transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Peroxisomal oxidation of very long chain fatty acids produces this

A

H2O2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hydroxyl radicals form in the presence of these:

A

Hydrogen peroxide and either superoxide or iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Iron in the presence of hydrogen peroxide may form this

A

Hydroxyl radicals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When oxygen is reintroduced to tissue after a period of deprivation and results in lots of ROS formation and tissue damage

A

Reperfusion injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Protective enzyme that converts superoxides to hydrogen peroxide

A

Superoxide dismutase (SOD)

19
Q

Superoxide dismutase (SOD) converts superoxides to this

A

Hydrogen peroxide

20
Q

Loss of this gradient during anoxia is related to ROS formation on reperfusion

A

Loss of Ca2+ gradient

21
Q

Source of ROS that is regulated by Ca2+ and stimulates relaxation of smooth muscle, vasodilation of vessels

A

Endothelial nitric oxide synthase (eNOS)

22
Q

Source of ROS that provides a protective mechanism in macrophages and astroglia
Provides high levels of NO to kill bacteria

A

Inducible nitric oxide synthase (iNOS)

23
Q

Enzyme in phagocytic cells that produces superoxide, which is converted to H2O2

A

NADPH oxidase

24
Q

Enzyme in phagocytic cells that produces HOCl (bleach) to kill bacteria

A

Myeloperoxidase

25
Q

Enzyme in phagocytic cells that produces NO to kill bacteria and pathogens

A

Nitric oxide synthase II

26
Q

Condition that involves a lack of NADPH oxidase
Results in susceptibility to bacterial, fungal infections and abnormal inflammatory responses

A

Chronic granulomatous disease

27
Q

Some amytropic lateral sclerosis (Lou Gehrig’s disease) is caused by a genetic defect in this

A

Superoxide dismutase (SOD)

28
Q

Effect of a total lack of superoxide dismutase (SOD)

A

Fatal

29
Q

Peroxisomal enzyme that works with SOD to protect against ROS

A

Catalase

30
Q

Vitamin E, flavenoids, and ascorbic acid are examples of this

A

Antioxidants

31
Q

Non-enzymatic free radial terminators

A

Antioxidants

32
Q

Tripeptide of y-glutamyl-cysteinyl-glycine that protects against ROS

A

Glutathione

33
Q

Enzyme that reduces glutathione using NADPH from the pentose phosphate pathway

A

Glutathione reductase

34
Q

This enzyme is often deficient in people with origins in the malarial belt because it is protective against malaria

A

Glucose-6-phosphate dehydrogenase

35
Q

Deficiency of Glucose-6-phosphate dehydrogenase causes protection against malaria, but lowers levels of this

A

NADPH –> results in oxidative damage from H2O2

36
Q

Particles of damaged hemoglobin from ROS

A

Heinz bodies

37
Q

Glycosaminoglycan that is non-sulfated and serves as lubricant and shock absorbant

A

Hyaluronic acid

38
Q

Most abundant GAG in the body
Bind to collagen in cartilage and hold fibers in a tight, strong network

A

Chondroitin 4- and 6- sulfates

39
Q

Mucopolysaccharidosis that is very severe and is a alpha-L-iduronidase deficiency
Corneal clouding, mental retardation, dwarfing, coarse facial features
Degradation of dermatan sulfate and heparan sulfate are affected

A

Hurler syndrome

40
Q

Mucopolysaccharidosis that is an iduronate sulfatase deficiency
X-linked
Wide range of severity; no corneal clouding but physical deformity and mental retardation (mild to severe)
Degradation of dermatan sulfate and heparan sulfate are affected

A

Hunter syndrome

41
Q

Lysosomal storage disease that is severe and involves corneal clouding

A

Hurler syndrome

42
Q

Lysosomal storage disease that is X-linked and involves no corneal clouding

A

Hunter syndrome

43
Q

Deficiency of the ability to phosphorylate mannose
Skeletal abnormalities, restricted joint movement, coarse facial feature, severe psychomotor impairment

A

I-cell disease